CHR Metz-Thionville
Metz, France
NCT Number: NCT07624981
Actinic keratoses are precancerous skin lesions that are the most common among all cancers and precancerous conditions in fair-skinned populations. The distinctive feature of these actinic keratoses is that some progress into skin cancers known as cutaneous carcinomas, while others regress spontaneously; currently, there is no way to distinguish between them, either through clinical observation or biological methods. The goal of the Diagno-KA project is to develop a diagnostic test that would distinguish between actinic keratoses that progress to cancer-so they can be surgically removed early (before they become severe and metastasize)-and those that regress, thereby avoiding unnecessary surgical intervention (to prevent scarring).
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
Metz, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Until the end of the study on average 2 years
Centre Hospitalier Régional Metz-Thionville
Other
Acronym: DIAGNO-KA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07406022
Diagnostic, Disease
Metz, France
View Trial DetailsNCT07177638
Carcinoma, Carcinoma, Basal Cell
Brooklyn, New York, United States
View Trial DetailsNCT05634252
Burns, Neoplasms
Salt Lake City, Utah, United States
View Trial DetailsNCT05520099
Adenocarcinoma, Bladder Cancer
Little Rock, Arkansas, United States
View Trial Details